UBS Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

UBS Group’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-65,700	Closed	-$302K	–	8429
2016 Q1	$302K	Hold	65,700	–	–	﹤0.01%	4182
2015 Q4	$342K	Buy	65,700 +40,700	+163%	+$236K	﹤0.01%	4244
2015 Q3	$151K	Hold	25,000	–	–	﹤0.01%	4872
2015 Q2	$395K	Buy	+25,000	New	+$304K	﹤0.01%	4312

UBS Group's RPTP Position: Q4 2016 in Review

UBS Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 2,100 shares — an estimated $19K sold.

UBS Group first reported a position in RPTP in Q4 2014 and held it in 8 quarters. The position peaked at $760K in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

UBS Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
UBS Group sold 2,100 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $19K.
UBS Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2014 and held it in 8 quarters.
UBS Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $760K in Q4 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.